Drug development

Genomics has the potential to significantly improve the efficacy of drugs and develop targeted therapies.

CRISPR For Genome Editing

CRISPR, a pioneering genome-editing technique, technology will allow AstraZeneca to identify and validate new drug targets in preclinical models that closely resemble human disease.

Curing The Un-Curable

Michael Vellard is a specialist in developing therapies for difficult to treat rare genetic diseases. Read the story behind his remarkable success.